Related Experiment Video
Updated: Aug 9, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa
Ines Schneider1, Anne Marie Queenan, Adolf Bauernfeind
1MICOER Institute, Hesseloherstrasse 4, 80802 Munich, Germany.
Abstract:
Pandoraea spp. are gram-negative, glucose nonfermenting rods detectable in blood cultures and sputa of cystic fibrosis patients. They are resistant to various antibiotic groups, with imipenem being the only active beta-lactam. We isolated an imipenem-resistant (MIC, 64 microg/ml) Pandoraea pnomenusa strain from a cystic fibrosis patient. Cloning and sequencing identified two beta-lactamases of Bush group 2d, namely, the known OXA-33, located on an integron, and the novel carbapenem-hydrolyzing oxacillinase OXA-62. OXA-62 is only distantly related to other oxacillinases (OXA-50 being closest with 43% amino acid identity). It hydrolyzes penicillins, oxacillin, imipenem, and meropenem but not expanded-spectrum cephalosporins. The blaOXA-62 gene is chromosome located. No transposable elements were found in its genetic neighborhood. With OXA-62-specific primers, blaOXA-62 could be identified in all P. pnomenusa strains and appears to be species specific. This additional mechanism of carbapenem resistance further complicates the treatment of infections caused by P. pnomenusa.
Insights
A novel carbapenem-hydrolyzing oxacillinase, OXA-62, was discovered in Pandoraea pnomenusa, an antibiotic-resistant bacterium. This finding complicates treatment for cystic fibrosis patients infected with this species.
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Pandoraea spp. are gram-negative bacteria found in cystic fibrosis patients.
- These bacteria exhibit resistance to multiple antibiotic classes, with limited treatment options.
Purpose of the Study:
- To investigate the mechanism of imipenem resistance in a Pandoraea pnomenusa strain.
- To identify and characterize novel beta-lactamases responsible for carbapenem resistance.
Main Methods:
- Isolation and characterization of Pandoraea pnomenusa.
- Cloning and sequencing of beta-lactamase genes.
- Determination of beta-lactamase activity against various antibiotics.
Main Results:
- Identification of two beta-lactamases: OXA-33 and a novel carbapenem-hydrolyzing oxacillinase, OXA-62.
- OXA-62 confers resistance to penicillins, oxacillin, imipenem, and meropenem.
- The blaOXA-62 gene is chromosomally located and appears specific to P. pnomenusa strains.
Conclusions:
- OXA-62 represents a new mechanism of carbapenem resistance in Pandoraea pnomenusa.
- The presence of OXA-62 complicates treatment strategies for P. pnomenusa infections.
- Further research is needed to understand the prevalence and clinical impact of OXA-62.
Related Concept Videos
Antibiotic Selection
Clinical Significance of Antibiotic Resistance
Production of Antibiotics
Gene Regulation in Microbial Communities: Quorum Sensing
